Galectin Therapeutics Inc. (NASDAQ:GALT) Long-Term Investor Alert: Investigation of Potential Wrongdoing
The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) was initiated concerning potential breaches of fiduciary duties by certain directors and officers of Galectin Therapeutics.
View full press release